These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37451940)

  • 1. Corrigendum to "Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus" [Eur. J. Pharmacol. 728 (5 April 2014) 128-134].
    Patel BM; Raghunathan S; Porwal U
    Eur J Pharmacol; 2023 Sep; 954():175900. PubMed ID: 37451940
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus.
    Patel BM; Raghunathan S; Porwal U
    Eur J Pharmacol; 2014 Apr; 728():128-34. PubMed ID: 24530414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder" [Eur. J. Pharmacol. 15 (2017) 809: 141-150].
    Zhao XJ; Yang YZ; Zheng YJ; Wang SC; Gu HM; Pan Y; Wang SJ; Xu HJ; Kong LD
    Eur J Pharmacol; 2021 Oct; 909():174440. PubMed ID: 34450555
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Tumor suppression effects of myoepithelial cells on mice breast cancer" [Eur. J. Pharmacol. 765 (2015) 171-178].
    Farhangi B; Latifpour M; Alizadeh AM; Khodayari H; Khodayari S; Khaniki M; Ghasempour S
    Eur J Pharmacol; 2016 Jul; 782():119. PubMed ID: 27180042
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Essential role of Ca
    Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
    Eur J Pharmacol; 2021 Feb; 892():173795. PubMed ID: 33358247
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "siRNA: Mechanism of action, challenges, and therapeutic approaches" [Eur. J. Pharmacol. 905 (2021) 174178].
    Alshaer W; Zureigat H; Al Karaki A; Al-Kadash A; Gharaibeh L; Hatmal MM; Aljabali AAA; Awidi A
    Eur J Pharmacol; 2022 Feb; 916():174741. PubMed ID: 34998574
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model" [Eur J Pharmacol. 718 (1-3) (2013) 105-13].
    Chang G; Zhang P; Ye L; Lu K; Wang Y; Duan Q; Zheng A; Qin S; Zhang D
    Eur J Pharmacol; 2020 Feb; 869():172876. PubMed ID: 31877280
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "The prophylaxis and treatment potential of supplements for COVID-19" [Eur. J. Pharmacol. 887 (15 November 2020) 173530].
    Sahebnasagh A; Saghafi F; Avan R; Khoshi A; Khataminia M; Safdari M; Habtemariam S; Ghaleno HR; Nabavi SM
    Eur J Pharmacol; 2024 Jun; 972():176571. PubMed ID: 38614058
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis" [Eur. J. Pharmacol. 779 (2016) 20-30 doi: 10.1016/j.ejphar.2016.02.067].
    Huang SS; Chen DZ; Wu H; Chen RC; Du SJ; Dong JJ; Liang G; Xu LM; Wang XD; Yang YP; Yu ZP; Feng WK; Chen YP
    Eur J Pharmacol; 2024 Aug; 977():176713. PubMed ID: 38849042
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Flaccidoside II ameliorates collagen-induced arthritis in mice" [Eur. J. Pharmacol. 880 (2020) 173155].
    Zhang GB; Jia ZJ; Zhang MH; Li YJ; Tian LY; Cheng J
    Eur J Pharmacol; 2021 Apr; 897():173963. PubMed ID: 33674037
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice" [Eur. J. Pharmacol. 666 (2011) 196-204].
    Li JM; Zhang X; Wang X; Xie YC; Kong LD
    Eur J Pharmacol; 2022 Feb; 916():174740. PubMed ID: 34996605
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to: "Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice": [Eur.J.Pharmacol.670(2011)441-447].
    Tsai SJ; Chao CY; Yin MC
    Eur J Pharmacol; 2018 Jan; 819():293. PubMed ID: 29325911
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "P2Y14 receptor in trigeminal ganglion contributes to neuropathic pain in mice" [Eur. J. Pharmacol. 931 (2022) 175211].
    Lin J; Fang X; Liu F; Zhang Y; Li Y; Fang Z; Tang Q; Li C; Zhou C; Shen J
    Eur J Pharmacol; 2022 Oct; 932():175266. PubMed ID: 36096845
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension" [Eur. J. Pharmacol. 943 (2023) 175558].
    Abdulkareem AO; Tiwari P; Lone ZR; Iqbal H; Gupta S; Jha RK; Chanda D; Jagavelu K; Hanif K
    Eur J Pharmacol; 2023 Jul; 950():175750. PubMed ID: 37147146
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Sulfur dioxide derivatives attenuates consolidation of contextual fear memory in mice" [Eur. J. Pharmacol. 914 2021 174658].
    Wang X; Zhao Y; Shi X; Gong M; Hao Y; Fu Y; Velez de-la-Paz OI; Wang X; Du Y; Guo X; Song L; Meng L; Gao Y; Yin X; Wang S; Shi H; Shi Y
    Eur J Pharmacol; 2022 Mar; 918():174794. PubMed ID: 35125204
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes" [Eur. J. Pharmacol. 776 (2016) 26-33].
    Guo Y; Zhang L; Li F; Hu CP; Zhang Z
    Eur J Pharmacol; 2016 Jul; 782():120. PubMed ID: 27180043
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632].
    Dutta AK; Santra S; Harutyunyan A; Das B; Lisieski MJ; Xu L; Antonio T; Reith MEA; Perrine SA
    Eur J Pharmacol; 2022 Oct; 933():175286. PubMed ID: 36167739
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632-172640].
    Dutta AK; Santra S; Harutyunyan A; Das B; Lisieski MJ; Xu L; Antonio T; Reith MEA; Perrine SA
    Eur J Pharmacol; 2022 Sep; 931():175232. PubMed ID: 36038378
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Identifying chronic alcoholism drug disulfiram as a potent DJ-1 inhibitor for cancer therapeutics" [Eur. J. Pharmacol. 926 (2022) 175035].
    Wu Q; Zhang M; Wen Y; He P; He Q; Yang B; Jiang L; Yuan M; Cao J
    Eur J Pharmacol; 2023 Mar; 942():175527. PubMed ID: 36707375
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin pathway" [Eur. J. Pharmacol. 865 (2019) 172787].
    Li LY; Yang CC; Yang JF; Li HD; Zhang BY; Zhou H; Hu S; Wang K; Huang C; Meng XM; Zhou H; Zhang L; Li J; Xu T
    Eur J Pharmacol; 2020 Feb; 869():172848. PubMed ID: 31843196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.